Next Article in Journal
Trends in Real-World Clinical Outcomes of Patients with Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small Cell Lung Cancer (NSCLC) Receiving One or More ALK Tyrosine Kinase Inhibitors (TKIs): A Cohort Study in Ontario, Canada
Next Article in Special Issue
Understanding the Immune System and Biospecimen-Based Response in Glioblastoma: A Practical Guide to Utilizing Signal Redundancy for Biomarker and Immune Signature Discovery
Previous Article in Journal
Real-World Efficacy and Safety of Avelumab Plus Axitinib in Metastatic Renal Cell Carcinoma: Results from the Ambispective RAVE-Renal Study
Previous Article in Special Issue
Whose Responsibility Is It? Implementing Patient-Prioritized Healthcare System Change in Oncology
 
 
Article

Article Versions Notes

Curr. Oncol. 2025, 32(1), 12; https://doi.org/10.3390/curroncol32010012
Action Date Notes Link
article xml file uploaded 27 December 2024 11:35 CET Original file -
article xml uploaded. 27 December 2024 11:35 CET Update https://www.mdpi.com/1718-7729/32/1/12/xml
article pdf uploaded. 27 December 2024 11:35 CET Version of Record https://www.mdpi.com/1718-7729/32/1/12/pdf
article html file updated 27 December 2024 11:36 CET Original file https://www.mdpi.com/1718-7729/32/1/12/html
Back to TopTop